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Recently, evidence has emerged that heptaspanning
membrane or G protein-coupled receptors may be
linked to intracellular proteins identified as regulators
of receptor anchoring and signaling. Using a yeast two-
hybrid screen, we identified -actinin, a major F-actin-
cross-linking protein, as a binding partner for the C-
terminal domain of the adenosine A2A receptor (A2AR).
Colocalization, co-immunoprecipitation, and pull-down
experiments showed a close and specific interaction be-
tween A2AR and -actinin in transfected HEK-293 cells
and also in rat striatal tissue. A2AR activation by agonist
induced the internalization of the receptor by a process
that involved rapid -arrestin translocation from the
cytoplasm to the cell surface. In the subsequent receptor
traffic from the cell surface, the role of actin organiza-
tion was shown to be crucial in transiently transfected
HEK-293 cells, as actin depolymerization by cytochala-
sin D prevented its agonist-induced internalization.
A2ACTR, a mutant version of A2AR that lacks the C-
terminal domain and does not interact with -actinin,
was not able to internalize when activated by agonist.
Interestingly, A2ACTR did not show aggregation or
clustering after agonist stimulation, a process readily
occurring with the wild-type receptor. These findings
suggest an -actinin-dependent association between the
actin cytoskeleton and A2AR trafficking.
Adenosine is a molecule that plays a regulatory role in the
nervous system, acting presynaptically, postsynaptically,
and/or non-synaptically (1). Adenosine mediates its actions
through activation of specific G protein-coupled heptaspanning
membrane receptors, for which four subtypes have been iden-
tified (A1R,
1 A2AR, A2BR, and A3R) (2). A2ARs are coupled
mostly to Gs proteins (3), thus being mainly linked to adenylyl
cyclase activation. The role of A2AR in the control of neuro-
transmitter release has been studied in several brain regions
as well as in the peripheral nervous system (4). Compared with
the other adenosine receptor subtypes, A2ARs are specially
concentrated in the striatopallidal complex (5). Using ultra-
structural techniques, Hettinger et al. (6) have recently dem-
onstrated that A2ARs are mostly localized postsynaptically in
dendrites and dendritic spines of rat striatal GABAergic
(where GABA is -aminobutyric acid) neurons. The membrane
expression and localization of A2AR are the result of ligand-
mediated clustering, internalization, and receptor trafficking
(7).
-Actinin is a major F-actin-cross-linking protein present in
both muscle and non-muscle cells. There are four -actinin
genes: two non-skeletal muscle isoforms (-actinin-1 and -4)
and two skeletal muscle isoforms (-actinin-2 and -3) (8), all of
which share a general structure, which can be divided into
three functionally distinct domains: the N terminus, which
contains two calponin homology domains and which mediates
the interaction with actin; a central region composed of four
spectrin-like motifs; and the C terminus, which contains EF-
hand domains. Recently, the spatial expression of -actinin-2
in the rat central nervous system was analyzed, revealing that
the highest levels of the protein are found in the striatum,
cortex, and hippocampus, where it has been shown to interact
with the glutamate NMDA receptor (9).
In this study, using a yeast two-hybrid approach and com-
plementary biochemical techniques, we provide evidence for
the existence of a physical interaction between A2AR and -ac-
tinin. Furthermore, we also demonstrate that there is a func-
tional association between the actin cytoskeleton and A2AR and
more specifically with the receptor internalization process and
its membrane agonist-induced aggregation or clustering.
EXPERIMENTAL PROCEDURES
Plasmid Constructs
Two EcoRI-EcoRI fragments of the C-terminal tail of A2AR were
subcloned into the bait vector pHybLexA/Zeo (Invitrogen) and the bac-
terial expression vector pGEX-4T-1 (Amersham Biosciences). One frag-
ment coding for amino acids 293–412 (LA2A) was amplified using Taq
DNA polymerase (Sigma) and the following primers: FLA2A (5-TAA-
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GAATTCCGCGAGTTCCGCCAGACC-3) and RA2A (5-CCGGAATTC-
CAAGCCAACCAGAAAGATAAAG-3). For the second fragment coding
for amino acids 322–412 (SA2A), the following primers were used:
FSA2A (5-TAAGAATTCCGGGTCTTGGCAGCTCATGGC-3) and RA2A.
The FLAG epitope was introduced between amino acids 6 and 7 of human
A1R using the same PCR mutagenesis approach used for the A2AR-FLAG
construct (10). A mutant lacking the C-terminal domain of A2AR was
generated using A2AR-FLAG as the template and the following primers:
FA2A (5-CGGAATTCATGCCCATCATG-3) and RA2ACT (5-GCTCT-
AGACTAGTAGGCGTAGATGAAGGG-3). The sequences of the cDNAs
and their orientation in the vectors were confirmed by DNA sequencing.
-Arrestin-1-GFP, -arrestin-2-GFP, and -arrestin-1(S412D) were
kindly provided by Drs. J. L. Benovic, M. G. Caron, and R. J. Lefkowitz,
respectively.
Yeast Two-hybrid System
Yeast Two-hybrid Screening—A bait strain was created by trans-
forming pHybLex-LA2A into Saccharomyces cerevisiae strain L40 fol-
lowing the manufacturer’s instructions (Hybrid Hunter, Invitrogen).
The bait strain was cotransformed with a mouse brain cDNA library
constructed in the Gal4 activating domain vector pPC86 (Invitrogen),
and transformants were plated onto minimal yeast medium lacking
histidine, tryptophan, uracil, and lysine and containing 300 mg/ml
Zeocin (Invitrogen) and 5 mM 3-aminotriazole. Plates were incubated at
30 °C for 5 days, and yeast colonies that grew on histidine-deficient
medium were re-streaked onto fresh selective plates and assayed for
-galactosidase activity following the manufacturer’s instructions. Prey
plasmids were isolated from yeast and electroporated into Escherichia
coli XL-1Blue electrocompetent cells (Stratagene). The 5-end of each
clone was sequenced using a vector primer. To confirm the interaction
in yeast, purified prey plasmids and -actinin-3 2 were re-trans-
formed with the pHybLex-LA2A bait and with the empty bait vector
pHybLexA/Zeo and tested for growth on selective plates and -galacto-
sidase activity. Other control yeast strains used were the positive con-
trol strain containing pHybLexA/Zeo-dystrobrevin and pYESTrp-syn-
trophin plasmids and the negative control strain containing the empty
bait and prey vectors pHybLexA/Zeo and pYESTrp2 (Invitrogen).
Liquid -Galactosidase Assay—1.5 ml of each culture (grown for 48 h
at 30 °C) was spun, and the pellet was resuspended in 200 l of Z buffer
(60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, and 1 mM MgSO4, pH
7.0). A small amount of glass beads (425–600 m; Sigma) was added,
and the mixture was sonicated for 5–10 min. After cell lysis, the sam-
ples were spun to pellet the cell debris. 100 l of supernatant was
transferred to a new microcentrifuge tube, and 700 l of Z buffer
containing -mercaptoethanol (27 l/10 ml) was added. 150 l of 2.5
mg/ml o-nitrophenyl--D-galactopyranoside (Sigma) was added to the
sample, and the mixture was incubated at 37 °C for 3 h. The absorbance
was read at 420 nm and refers to the amount of protein present in each
sample.
Cell Culture and Transfection
HEK-293 cells were grown in DMEM (Sigma) supplemented with 1
mM sodium pyruvate, 2 mM L-glutamine, 100 units/ml penicillin/strep-
tomycin, and 10% (v/v) fetal bovine serum at 37 °C in an atmosphere of
5% CO2. HEK-293 cells growing in 25-cm
2 dishes or 20-mm coverslips
were transiently transfected with 10 g of DNA coding for the proteins
specified in each case by calcium phosphate precipitation (11). The cells
were harvested at either 24 or 48 h after transfection.
For primary cultures, striatal tissue from Sprague-Dawley rat em-
bryos was treated with trypsin (0.5 g/liter) and EDTA (2 g/liter) solution
(Sigma) for 10 min at 37 °C. Trypsinization was stopped by addition of
complete medium (DMEM containing Glutamax-I, 10% fetal calf serum,
and 50 g/ml gentamycin), and tissue was gently triturated (10 pas-
sages) with a flame-sterilized glass Pasteur pipette. Cells were plated at
4–5  104 cells/cm2 in DMEM containing Glutamax-I, 10% heat-inac-
tivated fetal bovine serum, and 50 g/ml gentamycin at 5% CO2 in
poly-D-lysine-coated glass coverslips, and the medium was replaced
after 1 h with DMEM containing 10% heat-inactivated FCS and 50
g/ml gentamycin. The next day, the cells were washed with DMEM,
and the medium was replaced with serum-free B27-supplemented neu-
robasal medium (Invitrogen) containing 50 g/ml gentamycin. The cells
were kept at 37 °C in an atmosphere of 5% CO2 for 2–3 weeks without
frequent medium change.
Gel Electrophoresis and Immunoblotting
SDS-PAGE was performed using 7.5 or 10% polyacrylamide gels.
Proteins were immunoblotted onto polyvinylidene difluoride mem-
branes (Immobilon-P, Millipore Corp.) using a semidry transfer system
and developed with an enhanced chemiluminescence detection kit
(Pierce) as described previously (12).
Expression of GST Fusion Proteins and Pull-down Assay
GST, GST-SA2A, and GST-LA2A recombinant fusion proteins were
expressed in E. coli strain BL21 (Promega) with 0.1 mM isopropyl--D-
thiogalactopyranoside (Sigma) for 3 h at 37 °C and purified on gluta-
thione-Sepharose (Amersham Biosciences) as described previously (12).
5 g of each protein was coupled to 100 l of a 50% (v/v) suspension of
glutathione-agarose beads (Sigma) in phosphate-buffered saline for 1 h
at 4 °C. Human embryonic kidney cells (HEK-293) were solubilized in
ice-cold RIPA buffer (50 mM Tris-HCl, pH 7.5, 1% Triton X-100, 0.5%
sodium deoxycholate, 0.2% SDS, 100 mM NaCl, and 1 mM EDTA) for 30
min at 4 °C. The solubilized material was centrifuged at 14,000 rpm for
20 min, and the supernatant was precleared with 100 l of the 50% (v/v)
suspension of glutathione-agarose beads for 1 h with constant rotation
at 4 °C. After the preclearing, supernatants were transferred to a clean
tube containing GST, GST-SA2A, or GST-LA2A coupled to glutathione-
agarose and incubated overnight with constant rotation at 4 °C. Sub-
sequently, the beads were washed twice with ice-cold lysis buffer (phos-
phate-buffered saline, pH 7.4, containing 1% (v/v) Nonidet P-40); twice
with 0.1% (v/v) of ice-cold RIPA buffer; and once with 50 mM Tris-HCl,
pH 7.5, 100 mM NaCl, and 1 mM EDTA. Then, 50 l of SDS-PAGE
sample buffer was added to each sample. Bound proteins were dissoci-
ated by heating at 37 °C for 1 h and resolved by SDS-PAGE on 7.5% gels
as described above.
Antibodies
An antiserum against the GST fusion protein containing amino
acids 322–412 (SA2A) of A2AR (designated as anti-CTA2A) was used
in this study. Immunization of rabbits and affinity purification of the
antisera were performed as described previously (12, 13). Other pri-
mary antibodies used were as follows: anti-calnexin monoclonal an-
tibody (Transduction Laboratories), anti-FLAG monoclonal antibody
(clone M2; Sigma), anti--actinin polyclonal antibody (Santa Cruz
Biotechnology), anti--actinin monoclonal antibody (Sigma), and an-
ti--arrestin polyclonal antibody Ab186 (1:1000 dilution) (14). The
secondary antibodies used were as follows: horseradish peroxidase-
conjugated goat anti-rabbit IgG (1:60,000 dilution; Pierce), horserad-
ish peroxidase-conjugated rabbit anti-mouse IgG (1:2000 dilution;
Dako Corp.), Alexa 488-conjugated goat anti-mouse IgG (1:1000 dilu-
tion) and Texas Red-conjugated goat anti-rabbit IgG (1:2000 dilution; both
from Molecular Probes, Inc.), and Cy3-conjugated donkey anti-mouse IgG
(1:250 dilution; Jackson ImmunoResearch Laboratories, Inc.).
Immunoprecipitation
Transfected HEK-293 cells were solubilized with ice-cold RIPA
buffer, and lysates were incubated with anti-FLAG monoclonal anti-
body (2 g/ml) or anti-CTA2A polyclonal antibody (2 g/ml) for 2 h.
Then, 40 l of a suspension of protein G or protein A cross-linked to
agarose beads (Sigma) was added, and the mixture was incubated
overnight with constant rotation at 4 °C. The beads were washed twice
with ice-cold RIPA buffer; twice with 0.1% (v/v) of ice-cold RIPA buffer;
and once with 50 mM Tris-HCl, pH 7.5, 100 mM NaCl, and 1 mM EDTA.
Subsequently, 50 l of SDS-PAGE sample buffer was added to each
sample. Immune complexes were dissociated by heating to 37 °C for 1 h
and resolved by SDS-PAGE on 7.5 or 10% gels as described above.
Biotinylation of Cell-surface Proteins
HEK-293 cells transiently transfected with A2AR-FLAG or A2ACTR-
FLAG were washed three times with borate buffer (10 mM H3BO3, pH
8.8, and 150 mM NaCl) and then incubated with 50 g/ml sulfosuccin-
imidyl 6-(biotinamido)hexanoate (Pierce) in borate buffer for 5 min at
room temperature. Cells were washed three times with borate buffer
and again incubated with 50 g/ml sulfosuccinimidyl 6-(bioti-
namido)hexanoate in borate buffer for 10 min at room temperature, and
100 mM NH4Cl was added for 5 min to quench the remaining biotin.
Cells were washed with Tris-buffered saline, disrupted with three 10-s
strokes in a Polytron, and centrifuged at 14,000 rpm for 30 min. The
pellet was solubilized in ice-cold lysis buffer for 30 min and centrifuged
at 14,000 rpm for 20 min. The supernatant was incubated with 80 l of
streptavidin-agarose beads (Sigma) for 1 h with constant rotation at
4 °C. Beads were washed twice with ice-cold lysis buffer, twice with2 D. J. Blake, manuscript in preparation.
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0.1% (v/v) of ice-cold lysis buffer, and once with ice-cold phosphate-
buffered saline. The complexes were dissociated by adding 50 l of
SDS-PAGE sample buffer, heated at 37 °C for 1 h, and then resolved by
SDS-PAGE on 10% gels. The gels were run and immunoblotted as
described above.
Immunocytochemistry
Transiently transfected HEK-293 cells or rat striatal primary cul-
tures were fixed in 4% paraformaldehyde for 15 min and washed with
phosphate-buffered saline containing 20 mM glycine (buffer A) to
quench the remaining free aldehyde groups. Cells were permeabilized
with buffer A containing 0.2% Triton X-100 for 5 min. Blocking was
done using buffer A containing 1% bovine serum albumin (buffer B).
Cells were labeled for 1 h at room temperature with the indicated
primary antibody, washed for 30 min with buffer B, and stained with
the corresponding secondary antibody for 1 h. Coverslips were rinsed
for 30 min with buffer B and mounted with Immuno Fluore mounting
medium (ICN). An Olympus FV 300 scanning laser confocal microscope
was used for observations.
RESULTS
Yeast Two-hybrid Screening—To identify intracellular pro-
teins interacting with A2AR, the last 120 amino acids of A2AR
were fused in-frame with LexA in the pHybLexA/Zeo vector
(LA2A) (Fig. 1A) and used to screen a mouse brain cDNA
library with the yeast two-hybrid system. Of the 24 clones
(from the 2 106 total transformants screened that were found
to grow on nutritionally deficient plates and activated the
-galactosidase assay), seven were identified as different iso-
forms of the actin-binding protein -actinin: three independent
clones for -actinin-1, another three for -actinin-4, and one
clone for -actinin-2. To discard a false-positive interaction, all
four different -actinin isoforms were transformed again with
LA2A and plated along with different negative and positive
controls. As shown in Fig. 1A, only those transformants con-
taining the C-terminal tail of A2AR and any of the -actinins
could grow on deficient medium and turned blue in the -ga-
lactosidase assay, as did the positive control dystrobrevin/syn-
trophin (DB/SYN) (15). To determine the region of the C-
terminal domain of A2AR that interacts with -actinin, another
LexA fusion protein of the last 91 amino acids of the receptor
was constructed (SA2A) (Fig. 1B) and tested for its ability to
bind -actinin. This shorter fusion protein could not interact
with any of the -actinin isoforms (Fig. 1, B and C), thus
mapping the interacting domain within amino acids 293–321 of
A2AR. The interaction of both the LA2A and SA2A constructs
and -actinins was quantitated using a liquid -galactosidase
FIG. 1. -Actinin interacts with A2AR in the yeast two-hybrid system. A, schematic representation of the pHybLex-LA2A (LA2A) fusion
protein containing amino acids (AA) 293–412 of the C-terminal tail of A2AR (upper panel). Shown are the results from -galactosidase filter assays
and growth assays on yeast cotransformed with the bait and prey plasmids indicated (lower panels). B, schematic representation of the
pHybLex-SA2A (SA2A) fusion protein containing amino acids 322–412 of the C-terminal tail of A2AR (upper panel). Shown are the results from
-galactosidase filter assays and growth assays on yeast cotransformed with the bait and prey plasmids indicated (lower panels). In A and B, yeast
cells containing interacting clones are indicated by their growth on histidine-deficient medium and by the blue color corresponding to -galacto-
sidase activity. C, quantitation of the interaction of each -actinin isoform with A2AR fusion proteins determined using a liquid -galactosidase
(/Gal) assay as described under “Experimental Procedures.” Data are means  S.E. of three replicates. ACT1, ACT2, ACT3, and ACT4,
-actinin-1, -2, -3, and -4, respectively; DB, -dystrobrevin; SYN, syntrophin; pHYB, pHybLex; pYES, pYESTrp2; 7TM, seven-transmembrane
domain.
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assay (Fig. 1C), showing the clearly different binding abilities
of both A2AR constructs and confirming the region between
amino acids 293 and 321 as the -actinin-interacting domain.
-Actinin Binds to the C-terminal Domain of A2AR—To verify
the interaction between -actinin and the C-terminal tail of
A2AR, we tested the ability of naturally expressed full-length
-actinin to associate with GST fusion proteins containing the
LA2A and SA2A C-terminal regions of A2AR (GST-LA2A and
GST-SA2A). As shown in Fig. 2, an immunoreactive band of
100 kDa corresponding to -actinin endogenously expressed by
HEK-293 cells could be detected in the crude extracts from
these cells. This band was observed in pull-down assays when
cell lysates were incubated with GST-LA2A fusion protein, but
was not detected either with GST-SA2A fusion protein or with
GST alone (Fig. 2). This result shows that naturally expressed
-actinin binds specifically to a region in A2AR between amino
acids 293 and 321.
Interaction of A2AR and -Actinin in Transfected HEK-293
Cells—The association of A2AR and -actinin was subsequently
studied in transfected HEK-293 cells by double immunolabel-
ing and co-immunoprecipitation experiments. By confocal mi-
croscopy analysis of HEK-293 cells transiently transfected with
the cDNA coding for A2AR-FLAG, a marked overlap in the
distribution of the two proteins was found (Fig. 3A). Interest-
ingly, when the double immunolabeling experiment was per-
formed in HEK-293 cells transiently transfected with the
cDNA coding for A1R-FLAG (another adenosine receptor sub-
type with a shorter C-terminal tail) or with the cDNA coding
for a mutant of A2AR lacking the whole C-terminal domain
(A2ACTR-FLAG), no colocalization with -actinin was ob-
served (Fig. 3A), suggesting a specificity for the colocalization
between A2AR-FLAG and -actinin.
When cell extracts of HEK-293 cells transiently transfected
with A2AR-FLAG were immunoprecipitated with an antibody
against the FLAG epitope and these immunoprecipitates were
analyzed by Western blotting using an antibody against -ac-
tinin, a band of 100 kDa corresponding to -actinin was ob-
served (Fig. 3B, lane 4). Interestingly, this band did not appear
in immunoprecipitates from cells transfected with the cDNAs
coding for LacZ (Fig. 3B, lane 1), A1R-FLAG (lane 2), and
A2ACTR-FLAG (lane 3). These results demonstrate that -ac-
tinin can interact with full-length A2AR; that the interaction is
mediated by the C-terminal tail of A2AR; and that the A2AR/-
actinin interaction is receptor subtype-specific, as A1R did not
interact with -actinin.
Interaction of A2ARs with -Actinin in Rat Striatal Homoge-
nates and Primary Rat Striatal Neurons—To assess the phys-
iological relevance of the A2AR/-actinin interaction, we per-
formed co-immunoprecipitation experiments with rat striatal
homogenates and double immunolabeling with primary cul-
tures of rat striatal neurons. Using soluble extracts from rat
striatum that had been shown by Western blotting to contain
both -actinin and A2AR (Fig. 4A, lane 1), anti-CTA2A antibody
could immunoprecipitate a band of 100 kDa that was de-
tected with -actinin antibody (lane 2). This band did not
appear when protein A-agarose was used for immunoprecipi-
tation (Fig. 4A, lane 3), showing that there was no unspecific
interaction between -actinin and the resin.
The distribution of -actinin and A2AR in primary rat stria-
tal neurons was also tested. By confocal microscopy analysis, a
similar punctate distribution and a partial colocalization for
both proteins were found (Fig. 4B). Colocalization was not
FIG. 2. GST-LA2A and GST-SA2A pull-down experiments. En-
dogenously expressed -actinin in HEK-293 cell extracts (Crude) was
pulled down with GST-LA2A, but not with GST-SA2A or GST alone.
-Actinin was detected using a polyclonal antibody against -actinin
(1:500 dilution). The primary bound antibody was detected using a
horseradish peroxidase-conjugated goat anti-rabbit antibody (1:60,000
dilution). The lower panel shows the relative amounts of GST, GST-
SA2A, and GST-LA2A fusion proteins used in the pull-down experiment
stained with Coomassie Blue.
FIG. 3. Colocalization and co-immunoprecipitation of A2AR
and -actinin in HEK-293 cells. A, HEK-293 cells transiently trans-
fected with A2AR-FLAG, A1R-FLAG, or A2ACTR-FLAG and fixed and
permeabilized as described under “Experimental Procedures” were la-
beled with anti-FLAG monoclonal antibody (1:200 dilution) and anti--
actinin polyclonal antibody (1:100 dilution), followed by Texas Red-
conjugated goat anti-rabbit (1:2000 dilution) and Alexa 488-conjugated
goat anti-mouse (1:1000 dilution) antibodies. Cells were analyzed by
double immunofluorescence with a confocal microscope. Superimposi-
tion of images revealed colocalization of -actinin with A2AR-FLAG
(yellow, arrows), but not with A1R-FLAG or A2ACTR-FLAG. Scale
bar  10 m. B, anti-FLAG monoclonal antibody (2 g/ml) was used to
immunoprecipitate (IP) A2AR-FLAG, A1R-FLAG, and A2ACTR-FLAG
receptors transiently transfected in HEK-293 cells. The crude extracts
and immunoprecipitates were analyzed by SDS-PAGE and immuno-
blotted (IB) using a polyclonal antibody against -actinin (1:500 dilu-
tion) and a monoclonal antibody against the FLAG epitope (1:500 dilu-
tion). -Actinin was detected in crude extracts from HEK-293 cells
transfected with LacZ (lane 1), A1R-FLAG (lane 2), A2ACTR-FLAG
(lane 3), or A2AR-FLAG (lane 4), but it was detected only in those
immunoprecipitates of A2AR-FLAG-expressing cells. The lower panel
shows the ability of anti-FLAG antibody to immunoprecipitate A1R-
FLAG (lane 2), A2ACTR-FLAG (lane 3), and A2AR-FLAG (lane 4)
receptors from their respective extracts. The asterisk indicates a higher
molecular mass species of the A2ACTR-FLAG receptor.
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general, but it occurred both in the cell body, where the degree
of colocalization of A2AR with -actinin was very high (Fig. 4B,
arrows), and at specific aggregates in dendrites (arrowheads).
These observations are consistent with the idea that -actinin
and A2AR associate in striatal neurons.
Correlation between -Actinin Binding and A2AR Ligand-
induced Trafficking—Because of the role of -actinin in orga-
nizing and cross-linking actin filaments, we analyzed the pos-
sibility that the interaction between -actinin and A2AR
reported in this study could be related to the trafficking of the
receptor, both its clustering and internalization processes oc-
curring upon agonist stimulation. Although the agonist CGS-
21680 (2-p-(2-carboxyethyl)phenethylamino-5-N-ethylcarbox-
amidoadenosine) produces a marked internalization of A2AR
(7), the molecules involved in this process are not well known.
For example, the role of -arrestin proteins in the internaliza-
tion process of A2AR has not yet been described. Confocal scan-
ning microscopy was used to visualize in cotransfected cells the
possible translocation of -arrestin-1-GFP or -arrestin-2-GFP
from the cytoplasm to the cell surface. Fig. 5A shows that, in
the absence of agonist, -arrestin-1-GFP was homogeneously
localized in the cytosol of cells also expressing A2AR-FLAG.
Upon stimulation with 200 nM CGS-21680, a rapid (2 min)
translocation of -arrestin-1-GFP to the cell surface was ob-
served. Similar results were obtained when A2AR was cotrans-
fected with -arrestin-2-GFP (data not shown).
To further examine whether A2AR internalization is arrestin-
dependent, the receptor was cotransfected with -arrestin-
1(S412D), a mutant with dominant-negative properties with
respect to receptor internalization (16). To analyze the amount
of receptor in the plasma membrane, we isolated cell-surface
proteins by protein biotinylation using a membrane-imper-
meant biotin ester. Proteins isolated by streptavidin-agarose
affinity precipitation were analyzed by SDS-PAGE and immu-
noblotted with antibodies against the C-terminal tail of A2AR
(anti-CTA2A) and the endoplasmic reticulum-associated pro-
tein calnexin. The absence of calnexin in the streptavidin iso-
lates indicated that the biotin ester had not penetrated into the
cell and that it labeled only proteins in the plasma membrane
(Fig. 5B, lower panels). As shown in Fig. 5B, the overexpressed
arrestin mutant inhibited agonist-induced A2AR internaliza-
tion, indicating that A2AR is able to recruit -arrestin proteins
to the plasma membrane and that its agonist-dependent inter-
nalization process is, as in the case of other G protein-coupled
receptors of the same family, -arrestin-dependent (17, 18).
The effect of -actinin in the internalization process subse-
quent to -arrestin recruitment was determined by analyzing
the need of an intact actin cytoskeleton for receptor internal-
ization. HEK-293 cells transiently transfected with A2AR-
FLAG were pretreated with vehicle (Fig. 6, A and B) or with 2
M cytochalasin D for 2 h (C and D) as described previously
(19). After treatment, cells were incubated with vehicle (Fig. 6,
A and C, lane 1) or with 200 nM CGS-21680 (A and C, lane 2) for
2 h at 37 °C. After internalization, receptor recycling was as-
sessed by washing the cells after agonist treatment and further
FIG. 4. In vivo interaction of A2AR and -actinin in rat stria-
tum. A, solubilized extracts from rat striatum were subjected to immu-
noprecipitation analysis using anti-CTA2A antibody (2 g/ml). Extracts
(lane 1) and immunoprecipitates (lane 2) were analyzed by SDS-PAGE
and immunoblotted (IB) using anti--actinin polyclonal antibody (1:500
dilution) (upper panel) and the polyclonal antibody against A2AR, anti-
CTA2A antibody (Ab; 1:2000 dilution) (lower panel). Both A2AR and
-actinin could be detected in the crude extract (lane 1) and in the
immunoprecipitate (lane 2) with anti-CTA2A antibody, but they could
not be detected with protein-A agarose alone (lane 3). B, primary
cultures of rat striatal neurons (days in vitro 14–21) were cultured and
processed for immunolabeling as described under “Experimental Pro-
cedures” using affinity-purified anti-CTA2A polyclonal antibody (1:50
dilution) and anti--actinin monoclonal antibody (1:100 dilution). Cells
were analyzed by double immunofluorescence with a confocal micro-
scope. Superimposition of images revealed colocalization (yellow) both
in the cell body (arrows) and in dendrites (arrowheads). Scale bar 
10 m.
FIG. 5. Ligand-induced A2AR internalization. A, HEK-293 cells
transiently transfected with A2AR-FLAG (A2A-flag) plus -arrestin-1-
GFP (-arr1-GFP) were treated with vehicle (control (Ctrol)) or 200 nM
CGS-21680 for 2 min (2 min) at 37 °C. Then, cells were fixed as de-
scribed under “Experimental Procedures” and labeled with anti-FLAG
monoclonal antibody (1:200 dilution), followed by Cy3-conjugated don-
key anti-mouse antibody (1:1000 dilution). Cells were analyzed by dou-
ble immunofluorescence with a confocal microscope. Scale bar 10 m.
B, HEK-293 cells transiently transfected with A2AR-FLAG (lanes 1 and
2) or A2AR-FLAG plus -arrestin-1(S412D) (arr1 S412D) (lanes 3 and
4) were treated with vehicle (lanes 1 and 3) or with 200 nM CGS-21680
(lanes 2 and 4) for 2 h at 37 °C. Cell-surface labeling was performed as
described under “Experimental Procedures.” Crude extracts and bioti-
nylated proteins were subsequently analyzed by SDS-PAGE and immu-
noblotted using anti-CTA2A polyclonal antibody (1:2000 dilution), anti-
-arrestin polyclonal antibody Ab186 (1:1000 dilution), and anti-
calnexin monoclonal antibody (1:250 dilution).
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incubation for 1 h at 37 °C with fresh medium (Fig. 6, A and C,
lane 3). The results show that the amount of receptor present in
the cell surface decreased substantially in cells treated with
CGS-21680 (Fig. 6A, lane 2) compared with control cells (lane
1). When the agonist was washed out, the cell-surface expres-
sion of the receptor was partially recovered after 1 h (Fig. 6A,
lane 3). In contrast, pretreatment of cells with cytochalasin D
avoided agonist-induced internalization of A2AR (Fig. 6C, lane
2). Quantitation of the cell surface-associated receptor by den-
sitometric scanning of the immunoreactive bands on the films
indicated that agonist treatment or challenge induced an in-
ternalization of 74% of the total cell-surface receptor (Fig. 6B).
Under the same conditions, when cells were pretreated with
the actin-disrupting agent cytochalasin D, the agonist chal-
lenge did not induce internalization of the receptor (Fig. 6D).
These results indicate that a completely organized actin cy-
toskeleton is necessary for the agonist-dependent internaliza-
tion of A2AR. Moreover, the internalization ability of A2ACTR,
the C-terminal deletion mutant of A2AR that showed neither
colocalization nor co-immunoprecipitation with -actinin (Fig.
3), was tested. After agonist treatment of transiently trans-
fected cells with A2ACTR-FLAG, the membrane proteins were
isolated (see above) and analyzed by immunoblotting using
anti-FLAG antibody to detect A2ACTR-FLAG (Fig. 7). The
results show that the amount of receptor present at the plasma
membrane remained invariable after agonist treatment (Fig. 7,
lane 2) compared with the untreated cells (lane 1). Again, the
absence of calnexin in the streptavidin isolates indicated that
the biotin could not penetrate the cell (Fig. 7, lower panels).
Proper attachment of dopamine D2 receptors to the actin
cytoskeleton through the actin-binding protein filamin A has
been found to affect cell-surface clustering of this receptor (20).
To analyze the plasma membrane expression pattern of A2AR
as a function of its ability to bind -actinin, immunofluores-
cence experiments with A2AR-FLAG- and A2ACTR-FLAG-
transfected HEK-293 cells were performed. A2AR-FLAG was
shown to be uniformly expressed at the cell surface of HEK-293
cells (Fig. 8, Control). After 15 min of agonist treatment, a
marked aggregation or clustering of A2AR-FLAG at the cell-
surface level was observed (Fig. 8, 15 min). Moreover, when
cells were incubated for 2 h with the agonist, both cell-surface
clustering and a reduction in the total amount of plasma mem-
brane receptor were observed (Fig. 8, 2 h). These results agree
with the biotinylation ones (Fig. 6). Similarly, A2ACTR-FLAG
showed an even distribution at the plasma membrane level
when expressed in HEK-293 cells (Fig. 8, Control). Interest-
ingly, when treated with the agonist, the cell-surface distribu-
tion and amount of A2ACTR-FLAG were not altered compared
with the control cells (Fig. 8). This agrees with the previous
biotinylation results (Fig. 7). Overall, these results indicate
that the C-terminal domain of A2AR is essential for agonist-
induced clustering and internalization and suggest that a
proper attachment to the -actinin/actin cytoskeleton may be
crucial for A2AR trafficking.
DISCUSSION
A yeast two-hybrid approach was used to identify a novel
interaction between the heptaspanning membrane adenosine
A2A receptor and the actin-cross-linking protein -actinin. The
interaction was verified by pull-down experiments using GST
and A2AR-GST fusion constructs and by colocalization and co-
immunoprecipitation experiments in transfected HEK-293
cells. Moreover, colocalization of both proteins in rat striatal
primary cultures and the ability of anti-A2AR antibodies to
immunoprecipitate -actinin from rat striatal homogenates
suggest that the interaction is physiologically relevant.
-Actinin is a component of the actin cytoskeleton that plays
a central role by directly cross-linking the actin molecules, so
the presence of a complex involving A2AR and -actinin sug-
gests that -actinin may mediate receptor association with the
actin cytoskeleton. Recent studies have identified filamin A,
another actin-cross-linking protein similar to -actinin, as an
intracellular binding partner for other heptaspanning mem-
brane receptors, viz. the dopamine D2 and D3 receptors (20, 21),
the calcium-sensing receptor (22), and metabotropic glutamate
receptors (23). A role for these interactions in the proper mem-
brane targeting and synaptic localization of all these receptors
has been proposed. Filamin A plays a particularly important
FIG. 6. Effect of cytochalasin D on agonist-induced internal-
ization of A2AR. HEK-293 cells transiently transfected with A2AR-
FLAG were pretreated in the absence (A) or presence (C) of 2 M
cytochalasin D for 2 h and then treated with vehicle (lane 1) or with 200
nM CGS-21680 (lanes 2 and 3) for 2 h at 37 °C. To assess receptor
recycling (Rec) to the cell surface, cells were washed and incubated with
fresh medium for an extra hour at 37 °C (lane 3). Cell-surface labeling
was performed as described under “Experimental Procedures.” Crude
extracts and biotinylated proteins were subsequently analyzed by SDS-
PAGE and immunoblotted using anti-CTA2A polyclonal antibody (1:
2000 dilution) and anti-calnexin monoclonal antibody (1:250 dilution).
B and D are relative densitometric scans of the immunoblots in A and
C, respectively. Cell-surface receptor values were normalized using the
total amount of receptor in the crude extract for each sample. The
results are presented as means  S.E. of three independent experi-
ments. *, p  0.01 versus control (Ctrl) cells; **, p  0.05 versus
CGS-21680 (CGS)-treated cells.
FIG. 7. The C-terminal tail of A2AR is directly involved in its
agonist-induced internalization. HEK-293 cells transiently trans-
fected with A2ACTR-FLAG were treated with vehicle (lane 1) or with
200 nM CGS-21680 (lane 2) for 2 h at 37 °C. After this incubation period,
cells were processed for cell-surface biotinylation as described under
“Experimental Procedures.” Crude extracts and cell-surface biotiny-
lated proteins were subsequently analyzed by SDS-PAGE and immu-
noblotted using anti-FLAG monoclonal antibody (1:500 dilution) and
anti-calnexin monoclonal antibody (1:250 dilution).
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role in dopamine D2 receptor plasma membrane expression (21)
and cell-surface clustering (20). Similarly, one important result
achieved in this work is that the attachment of A2AR to the
actin cytoskeleton through -actinin was revealed as a prereq-
uisite for its agonist-induced plasma membrane clustering.
Although we present here the first evidence for binding of
-actinin to a heptaspanning membrane receptor, it has al-
ready been shown to interact with other types of cell receptors
such as the ATP-gated ion channel P2X7 (24) and glutamate
NMDA receptors, which are clustered and localized at postsyn-
aptic sites by interactions with postsynaptic density protein-95
(25) and -actinin-2 (26). An NMDA receptor and a -actinin-2
has been reported in rat cortex and striatum (9), specially in
the latter, where both -actinin-2 mRNA and protein were
shown to accumulate. Compared with other adenosine recep-
tors, A2AR is also specially concentrated in the striatum, where
we have found a close association with -actinin by colocaliza-
tion and co-immunoprecipitation studies. It should be noted
that, in rat striatal neurons, NMDA currents are inhibited by
the A2AR agonist CGS-21680. This inhibition was shown to be
dependent on an intact -actinin/actin cytoskeleton, as treat-
ment with the actin-depolymerizing agent cytochalasin B pre-
vents A2AR-induced NMDA current inhibition (27). Hence, the
actin cytoskeleton (and -actinin particularly) most likely has a
role in the functional regulation of NMDA action by A2AR in rat
striatum.
There is a growing body of evidence suggesting that actin
plays a role in endocytosis (28, 29). Using drugs that inhibit
proper actin polymerization, Lunn et al. (30) abrogated the
internalization of two heptaspanning membrane receptors, viz.
bombesin and endothelin receptors and the tyrosine kinase
receptor for epidermal growth factor. As receptor-mediated en-
docytosis is a critical phenomenon in receptor down-regulation,
ligand degradation, and signal termination, we were interested
in the potential role of actin in agonist-dependent A2AR inter-
nalization. In this work, a -arrestin-dependent mechanism for
A2AR agonist-induced internalization was demonstrated. A2AR
was able to rapidly recruit -arrestins to the cell surface upon
agonist challenge, and a negative mutant of -arrestin was
shown to inhibit agonist-induced A2AR internalization. In this
study, we examined the effect of cytochalasin D, an agent that
caps the growing end of actin filaments and thus disrupts
actively turning over actin stress fibers (31), on the endocytosis
of A2AR that occurs after -arrestin recruitment. Our results
show that, whereas A2AR can normally internalize in HEK-293
cells transiently transfected with A2AR-FLAG, the exposure of
these cells to cytochalasin D inhibits the internalization of the
receptor, confirming a functional relationship between A2AR
and the underneath actin structure and suggesting that this
internalization process depends on actively turning over actin
stress fibers rather than on cortical actin, which remains less
affected by the action of cytochalasin D (30, 31). Moreover, a
mutant of A2AR lacking the C-terminal domain, which could
not interact with -actinin in transfected HEK-293 cells, did
not internalize upon agonist exposure. These results show that
the C-terminal tail of A2AR is an essential domain for its
internalization; and as this domain mediates the interaction
with -actinin, they suggest that a proper attachment of the
receptor to the -actinin/actin cytoskeleton is a prerequisite for
its agonist-induced -arrestin-mediated internalization.
As recently proposed for other G protein-coupled receptors,
once internalized, the interaction between receptors and -ar-
restins also triggers the ERK cascade, where -arrestins can
behave as agonist-regulated molecular adapters and scaffolds
(32), thus allowing activated ERKs to target specific subcellu-
lar domains (33). -Actinin also interacts with proteins in-
volved in signal transduction such as the MEK activator
MEKK1 (34) and ERK (35). Recently, we reported that A2AR
can signal through the extracellular signal-regulated MAPK
cascade (10). Taking all this evidence together, it seems that,
apart from -arrestins, -actinin has a dual role as an actin
cytoskeleton component and as a scaffolding protein, anchoring
receptors to their target signaling molecules and so ensuring a
rapid and efficient signal transduction. A similar hypothesis
has been suggested for another actin-cross-linking protein, fil-
amin A, as this protein interacts with MEK1/2 and p38 kinases
(36) and the Ras-related GTPases Rac, RhoA, Cdc42, and RalA
(37). So, consistent with a double function as a scaffolding and
adapter protein, the interaction of filamin A increases the
coupling efficiency of the dopamine D2 receptor and adenylate
cyclase (20, 21). Moreover, -actinin-2 competes with calmod-
ulin for binding to the C-terminal domain of the NMDA NR1
subunit, which is involved in the calcium-dependent inactiva-
tion of the NMDA receptor (38, 39). This indicates that -acti-
nin-2 also plays a regulatory role in the calmodulin/NMDA
receptor interaction and does not merely anchor the receptor to
the actin cytoskeleton. Further studies to establish the effects
of -actinin in A2AR activation of either adenylate cyclase or
the ERK1/2 cascade in transfected cells as well as in neuronal
primary cultures will be needed to understand the role of the
cytoskeleton in adenosine neuromodulation.
In summary, a direct interaction between -actinin and
A2AR has been identified by the yeast two-hybrid system and
confirmed by convergent techniques in transfected HEK-293
cells and in more physiological models such as cultured neu-
rons and rat striatum. Finally, we have shown that agonist-
mediated clustering and internalization of A2AR are mediated
by its C-terminal tail and are dependent on an intact -actinin/
actin network, thus providing a functional link between this
adenosine receptor and the actin cytoskeleton.
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